Ben Izar's lab is a pioneer in combining single cell techniques, genome-editing, and systems biology to explore the cancer field’s most pressing problems.
Including BRCA1 testing with prenatal carrier screening could identify people at risk of breast, ovarian, and pancreatic cancer at a time when cancer screening could save their lives.
A study from Columbia researchers suggests that changing a single letter in the DNA code of selected genes in T cells may supercharge cell therapies against cancer.
Researchers at Columbia are tackling cancer disparities in northern Manhattan and surrounding areas through the National Cancer Institute’s network of community-based research programs.
Katherine Crew, MD, directs the Clinical Breast Cancer Prevention Program and cares for patients with breast cancer and women at high risk at Columbia University Irving Medical Center/NYP.
Exercise may lower breast cancer risk in all women and young survivors underutilize fertility-preservation services: These are among recent breast cancer findings from Columbia scientists.
Lisa Kachnic, MD, the new chair of radiation oncology at Columbia University Irving Medical Center, has helped pioneer techniques that deliver radiation therapy to cancer patients with more precision.
A new drug that penetrates the protective barrier around pancreatic cancers and accumulates in malignant cells may improve current chemotherapy, a study in mice suggests.
Researchers in Columbia's medical and engineering schools have edited a strain of non-pathogenic bacteria to colonize solid tumors in mice and safely deliver potent immunotherapies.
At Columbia, patients with brain cancer will be able to participate in a new type of clinical trial that promises to speed up the development of better drugs for glioblastoma.